Ranibizumab port delivery system in neovascular age-related macular degeneration

Ranibizumab has proven its efficacy in various retinal diseases and particularly in neovascular age-related macular degeneration (nAMD). The number of injections and the frequent follow-up visits has been burdensome to patients particularly during the COVID era. Ranibizumab port delivery system (RPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrasekaran, Priya R., Madanagopalan, V.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829724/
https://www.ncbi.nlm.nih.gov/pubmed/35155989
http://dx.doi.org/10.1177/25158414211072623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829724/
https://www.ncbi.nlm.nih.gov/pubmed/35155989
http://dx.doi.org/10.1177/25158414211072623

Ejemplares similares